Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of age group between 30-50 years willing to participate for the trial with a diagnosis of rheumatoid arthritis using theEULAR diagnostic criteria Diagnosed cases of Amavata based on symptoms and signs described in MadhavNidana. 3. Seropositive and Seronegative both cases are included. 4. Having history of less than 5 years.
Exclusion criteria
Exclusion criteria: Patients not willing to participate. 2. Patients having severe deformities. 3. Patients of Gouty Arthritis, Infective Arthritis, Osteoarthritis. 4. HIV, Tuberculosis, Hypertension, D.M., and other major systemic problems. 5. Pregnant & lactating women 6.Patients with major complications such as extra articular manifestations like leg ulcers, digital gangrene, Episcleritis, Endocarditis, pleural and pericardial effusions, neurological and haematologic manifestations etc. will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ï?·Both the drugs of the study are expected to be effective because these are mentioned specifically in Amvataprakran in classical text and all constituents are having properties opposite to Ama dosha Vedanashamak and ShothharaTimepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| ï?·there can be significant reduction in modern objective parameters like RA factor Anti CCP CRP So effect of Ayurvedic text formulations on Modern parameters can be proved by the studyTimepoint: 45 days | — |
Countries
India
Contacts
Shri Krishna Ayush University Kurukshetra